Cell and gene therapy development moves into cardiac indications
Drug Target Review
OCTOBER 2, 2024
Viral vectors, such as adeno-associated viruses (AAVs), are commonly used to deliver therapeutic genes to cardiac cells. RNA-based therapies, including mRNA and RNA interference (RNAi), are being explored to modulate gene expression in heart cells.
Let's personalize your content